Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3INDUSTRY 1FED 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Neoplasms 1Hot Flashes 1Depressive Disorder, Major 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Citalopram × Clear all
NCT05063604 2022-07-05

CAMAD

Hospital Universitari de Bellvitge

Phase 2 Terminated
40 enrolled
Breast

Breast Neoplasms

NCT01725048 2017-03-13

NRR

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
21 enrolled

Depressive Disorder, Major, Neoplasms

NCT00363909 2016-12-13

Citalopram in Treating Postmenopausal Women With Hot Flashes

Alliance for Clinical Trials in Oncology

Phase 3 Completed
254 enrolled
Breast

Breast Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡